PARATEK PHARMACEUTICALS INC
CUSIP 699374302
Paratek Pharmaceuticals Inc has 65 institutional holders in Filings Flow’s 13F database, together reporting 18.86M shares worth $57M as of Q4 2022. The largest reported holders are Equitec Proprietary Markets, LLC, Metlife Investment Management, LLC, and Css LLC/Il.
Institutional Holders
65
Q4 2022
Reported Value
$57M
Ticker
unmapped
private placement or foreign
Quarters Tracked
7
Ownership Trend
Institutional holders
Total reported value
Holders
Mixed quarters
| Manager | % of Portfolio | Value | Shares | Quarter |
|---|---|---|---|---|
| EQUITEC PROPRIETARY MARKETS, LLC$187M AUM | 0.07% | $215,917 | 97.7K | Q2 2023OLDER |
| CSS LLC/IL$2.1B AUM | 0.00% | $32,487 | 14.7K | Q2 2023OLDER |
| MetLife Investment Management, LLC$19.6B AUM | 0.00% | $112,089 | 21.5K | Q1 2024 |
| CITADEL ADVISORS LLC$618.5B AUM | 0.00% | $26,299 | 11.9K | Q2 2023OLDER |
Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.